Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ie-Ming Shih

Showing results (171-180 of 364) with videos related to

Pageof 37
Sort By:
Cancer Research|February 5, 2009
Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancerJung Hye Choi, Jim Jinn-Chyuan Sheu, Bin Guan, et al.
The American Journal of Pathology|November 9, 2013
Identification of the NAC1-regulated genes in ovarian cancerMin Gao, Ren-Chin Wu, Alice L Herlinger, et al.
Glycobiology|December 5, 2012
Polysialic acid enhances the migration and invasion of human cytotrophoblastsBethann S Hromatka, Penelope M Drake, Mirhan Kapidzic, et al.
The American Journal of Surgical Pathology|April 4, 2009
Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 casesEmanuela Veras, Tsui-Lien Mao, Ayse Ayhan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinomaM Herman Chui, Yihong Wang, Ren-Chin Wu, et al.
Oncotarget|July 1, 2021
Correction: <i>BRAF</i> -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinomaM Herman Chui, Susanne K Kjaer, Kirsten Frederiksen, et al.
Human Pathology|March 18, 2015
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 casesSheila F Faraj, Alcides Chaux, Nilda Gonzalez-Roibon, et al.
The Journal of Pathology|October 13, 2011
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesionsElisabetta Kuhn, Robert J Kurman, Russell Vang, et al.
Gynecologic Oncology|April 29, 2009
p53 autoantibodies, cytokine levels and ovarian carcinogenesisMiyun Tsai-Turton, Antonio Santillan, Dan Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinomaM Jim Yen, Chih-Yi Hsu, Tsui-Lien Mao, et al.
Pageof 37

Showing results (171-180 of 364) with videos related to

Sort By:
Pageof 37
Cancer Research|February 5, 2009
Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancerJung Hye Choi, Jim Jinn-Chyuan Sheu, Bin Guan, et al.
The American Journal of Pathology|November 9, 2013
Identification of the NAC1-regulated genes in ovarian cancerMin Gao, Ren-Chin Wu, Alice L Herlinger, et al.
Glycobiology|December 5, 2012
Polysialic acid enhances the migration and invasion of human cytotrophoblastsBethann S Hromatka, Penelope M Drake, Mirhan Kapidzic, et al.
The American Journal of Surgical Pathology|April 4, 2009
Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 casesEmanuela Veras, Tsui-Lien Mao, Ayse Ayhan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinomaM Herman Chui, Yihong Wang, Ren-Chin Wu, et al.
Oncotarget|July 1, 2021
Correction: <i>BRAF</i> -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinomaM Herman Chui, Susanne K Kjaer, Kirsten Frederiksen, et al.
Human Pathology|March 18, 2015
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 casesSheila F Faraj, Alcides Chaux, Nilda Gonzalez-Roibon, et al.
The Journal of Pathology|October 13, 2011
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesionsElisabetta Kuhn, Robert J Kurman, Russell Vang, et al.
Gynecologic Oncology|April 29, 2009
p53 autoantibodies, cytokine levels and ovarian carcinogenesisMiyun Tsai-Turton, Antonio Santillan, Dan Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinomaM Jim Yen, Chih-Yi Hsu, Tsui-Lien Mao, et al.
Pageof 37